| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3316293 | Pancreatology | 2016 | 6 Pages |
Abstract
The present results show that CEA level is an independent prognostic factor in patients with metastatic PC. A combination chemotherapy regimen may offer modest survival benefit in patients with high CEA.
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Hiroshi Imaoka, Nobumasa Mizuno, Kazuo Hara, Susumu Hijioka, Masahiro Tajika, Tsutomu Tanaka, Makoto Ishihara, Yutaka Hirayama, Nobuhiro Hieda, Tsukasa Yoshida, Nozomi Okuno, Yasuhiro Shimizu, Yasumasa Niwa, Kenji Yamao,